SCHEMBL19348482

SCHEMBL19348482

C1=CCNCC1.CC1(C)C=CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL472871 0.78
Cyclopentene SCHEMBL4558557 0.77
SCHEMBL17594966 0.77
SCHEMBL27444047 0.76
SCHEMBL27858829 0.76
Hydrochloric Acid SCHEMBL11048878 0.76
SCHEMBL4258461 0.76 CXCR4 (0.38)
Benzene SCHEMBL28446162 0.74
Ethylene SCHEMBL27304002 0.74
Methylamine SCHEMBL27476913 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3191483-B1 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF NORTH & SOUTH BROTHER PHARMACY INVESTMENT CO LTD (CN) 2020-06-10 EP disclosed
US-9951010-B2 Compounds as CRTH2 antagonist and uses thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-04-24 US disclosed
US-20170267634-A1 COMPOUNDS AS CRTH2 ANTAGONIST AND USES THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-09-21 US disclosed